|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Deferred rent | ||||||||||||||||||||
| Lease incentive receivable | ||||||||||||||||||||
| Rental properties, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Escrow deposits | ||||||||||||||||||||
| Capitalized project costs | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right of use asset, net | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Investment in unconsolidated joint ventures | ||||||||||||||||||||
| Investment in cost-method investees | ||||||||||||||||||||
| Interest rate swap asset | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Convertible debenture | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Derivative liability - interest rate swap, at fair value | ||||||||||||||||||||
| Security deposits payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized; 2,000,000 shares issued and outstanding on June 30, 2026 and December 31, 2025 ($1.00 per share liquidation preference or $2,000,000) | ||||||||||||||||||||
| Common stock: $0.001 par value, 100,000,000 shares authorized; 13,351,516 and 12,201,516 shares issued on June 30, 2026 and December 31, 2025, respectively, and 13,180,829 and 12,030,829 shares outstanding on June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost (100,000 shares on June 30, 2024 and December 31, 2023, respectively) | ||||||||||||||||||||
| Treasury stock, at cost (170,687 and 170,687 shares on June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
